Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	MPOS	POSD
	WDTC1(3.2%)	exon9,c.868del,p.E290fs	0.032	0.009967	449|16	120|0	0.02244	784|18	1	27621107	27621108	TG	T	panel_of_normals,slippage	WDTC1	NM_001276252.2	9	c.868del	p.Glu290fs	frameshift_variant				34	0.0
1	NRAS(0.2%)	exon4,c.437C>T,p.A146V	0.001741	0.001065	3745|6	3288|3	0.00129	27832|36	1	115252203	115252203	G	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				51	0.0
1	NRAS(0.1%)	exon2,c.38G>C,p.G13A	0.0009408	0.0007287	4327|3	3512|2	0.00057	33525|19	1	115258744	115258745	C	G	clustered_events,normal_artifact,weak_evidence	NRAS	NM_002524.5	2	c.38G>C	p.Gly13Ala	missense_variant	Pathogenic		Melanoma	31	0.0
1	NRAS(0.1%)	exon2,c.37G>T,p.G13C	0.000922	0.0003763	4330|4	3511|5	0.00172	33665|58	1	115258745	115258745	C	A	clustered_events,weak_evidence	NRAS	NM_002524.5	2	c.37G>T	p.Gly13Cys	missense_variant	Pathogenic		Melanoma	47	0.0
1	NRAS(0.1%)	exon2,c.35G>T,p.G12V	0.00117	0.00171	4319|5	3491|7	0.00149	32919|49	1	115258747	115258748	C	A	clustered_events,normal_artifact,weak_evidence	NRAS	NM_002524.5	2	c.35G>T	p.Gly12Val	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|Myelodysplastic_syndrome|Noonan_syndrome|Rasopathy|Malignant_neoplasm_of_body_of_uterus|not_provided	58	0.0
1	NRAS(0.2%)	exon2,c.35G>A,p.G12D	0.001519	0.0007314	4319|6	3491|2	0.00076	32919|25	1	115258747	115258748	C	T	clustered_events,normal_artifact,weak_evidence	NRAS	NM_002524.5	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Epidermal_nevus|Malignant_melanoma_of_skin|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|Myelodysplastic_syndrome|Malignant_neoplasm_of_body_of_uterus|not_provided	19	0.0
	SPTA1(28.3%)	exon20,c.2889C>T,p.N963=	0.283	0.077	94|34	17|0	0.23429	134|41	1	158626363	158626363	G	A	PASS	SPTA1	NM_003126.4	20	c.2889C>T	p.Asn963=	synonymous_variant				51	0.0
-	MSH6(6.0%)	exon5,c.3261del,p.F1088fs	0.06	0.05	2763|212	1124|69	0.04513	12315|582	2	48030639	48030640	AC	A	normal_artifact,panel_of_normals,slippage	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	38	0.0
	RANBP2(2.6%)	exon20,c.3501_3503del,p.D1168del	0.026	0.03	213|6	33|0	0.02624	334|9	2	109380484	109380487	GGAT	G	panel_of_normals,slippage	RANBP2	NM_006267.5	20	c.3501_3503del	p.Asp1168del	disruptive_inframe_deletion				42	0.0
	RANBP2(2.5%)	exon20,c.4459_4650del,p.A1487_S1550del	0.025	0.009074	1077|33	143|1	*	0|0	2	109381429	109381621	AAAGGAAGGACAGTGGGATTGCAGTGCATGTTTGGTACAAAATGAGGGGAGCTCTACAAAATGTGCTGCTTGTCAGAATCCGAGAAAACAGAGTCTACCTGCTACTTCTATTCCAACACCTGCCTCTTTTAAGTTTGGTACTTCAGAGACAAGTAAAACTCTAAAAAGTGGATTTGAAGACATGTTTGCTAAG	A	panel_of_normals	RANBP2	NM_006267.5	20	c.4459_4650del	p.Ala1487_Ser1550del	conservative_inframe_deletion				32	0.0
	LRP1B(1.5%)	exon10,c.1435C>A,p.P479T	0.015	0.083	378|6	14|0	0.00882	674|6	2	141812802	141812802	G	T	PASS	LRP1B	NM_018557.3	10	c.1435C>A	p.Pro479Thr	missense_variant				30	0.0
	BMPR2(1.2%)	exon12,c.1748del,p.N583fs	0.012	0.014	1737|23	843|9	0.01047	5671|60	2	203420129	203420130	GA	G	normal_artifact,panel_of_normals	BMPR2	NM_001204.7	12	c.1748del	p.Asn583fs	frameshift_variant	Pathogenic		Primary_pulmonary_hypertension	31	0.0
1	IDH1(0.2%)	exon4,c.395G>T,p.R132L	0.001852	0.0007555	2832|3	1732|0	0.00454	13362|61	2	209113112	209113112	C	A	clustered_events,orientation,strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.395G>T	p.Arg132Leu	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome	31	0.0
1	IDH1(0.2%)	exon4,c.394C>T,p.R132C	0.001703	0.0007476	2821|7	1724|0	0.00094	12714|12	2	209113113	209113113	G	A	clustered_events,weak_evidence	IDH1	NM_005896.4	4	c.394C>T	p.Arg132Cys	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome|not_provided	27	0.0
	ANO10(4.6%)	exon2,c.132del,p.D45fs	0.046	0.03	1710|94	455|17	0.05179	6408|350	3	43647212	43647213	CT	C	multiallelic,normal_artifact,panel_of_normals,slippage	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Spinocerebellar_ataxia	43	0.0
	ANO10(2.6%)	exon2,c.132dup,p.D45fs	0.026	0.029	1710|52	455|15	0.03450	6408|229	3	43647212	43647213	CT	CTT	multiallelic,normal_artifact,panel_of_normals,slippage	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Spinocerebellar_ataxia,_autosomal_recessive_10|Autosomal_recessive_cerebellar_ataxia|not_provided	42	0.0
	ATR(7.3%)	exon10,c.2320del,p.I774fs	0.073	0.056	2886|267	1930|145	0.05794	15722|967	3	142274739	142274740	AT	A	multiallelic,normal_artifact,panel_of_normals,slippage	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided	42	0.0
	ATR(2.2%)	exon10,c.2320dup,p.I774fs	0.022	0.051	2886|94	1930|118	0.05494	15722|914	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,panel_of_normals,slippage	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic		not_provided	41	0.0
1	PIK3CA(0.2%)	exon10,c.1633G>A,p.E545K	0.001789	0.001046	3131|5	1238|0	0.00077	19439|15	3	178936091	178936092	G	A	clustered_events,weak_evidence	PIK3CA	NM_006218.4	10	c.1633G>A	p.Glu545Lys	missense_variant	Pathogenic/Likely_pathogenic		Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Segmental_undergrowth_associated_with_lymphatic_malformation|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Sarcoma|Neoplasm_of_ovary|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Carcinoma_of_gallbladder|Breast_adenocarcinoma|Adenocarcinoma_of_prostate|Gallbladder_cancer|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|Eccrine_Angiomatous_Hamartoma|OVARIAN_CANCER,_EPITHELIAL,_SOMATIC|PIK3CA_related_overgrowth_spectrum|not_provided	53	0.0
1	PIK3CA(0.1%)	exon21,c.3139C>T,p.H1047Y	0.0009831	0.001324	4264|3	2670|3	0.00022	44899|10	3	178952084	178952085	C	T	clustered_events,normal_artifact,orientation,weak_evidence	PIK3CA	NM_006218.4	21	c.3139C>T	p.His1047Tyr	missense_variant	Pathogenic		Segmental_undergrowth_associated_with_mainly_venous_malformation_with_capillary_component|Hepatocellular_carcinoma|Medulloblastoma|Adrenocortical_carcinoma|Congenital_macrodactylia|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Epidermal_nevus|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Adenocarcinoma_of_prostate|Lung_carcinoma|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Cowden_syndrome_5|Cowden_syndrome|Familial_cancer_of_breast|Glioblastoma|Malignant_tumor_of_floor_of_mouth|Malignant_neoplasm_of_body_of_uterus|not_provided	25	0.0
	BCL6(6.5%)	exon5,c.854C>T,p.A285V	0.065	0.037	79|4	27|0	0.02985	130|4	3	187447339	187447339	G	A	panel_of_normals	BCL6	NM_001706.5	5	c.854C>T	p.Ala285Val	missense_variant				32	0.0
	MUC4(7.4%)	exon2,c.3017_3112del,p.A1006_H1037del	0.074	0.065	228|25	16|0	*	0|0	3	195515338	195515434	ACGTGACCTGTGGATTCTGAGGAAGTGTCGGTGACAGGAAGAGGGGTGGTGTGACCTGTGGATACTGAGGAAGGGCTGGTGACAGGAAGAGGGGTGG	A	haplotype,panel_of_normals	MUC4	NM_018406.7	2	c.3017_3112del	p.Ala1006_His1037del	disruptive_inframe_deletion				22	0.0
	MUC4(27.2%)	exon2,c.3111C>T,p.H1037=	0.272	0.154	78|26	6|0	0.25616	151|52	3	195515340	195515340	G	A	haplotype,panel_of_normals	MUC4	NM_018406.7	2	c.3111C>T	p.His1037=	synonymous_variant				14	0.0
	INPP4B(2.5%)	exon12,c.834C>T,p.C278=	0.025	0.02	224|6	59|1	0.01988	493|10	4	143159019	143159019	G	A	orientation	INPP4B	NM_001101669.3	12	c.834C>T	p.Cys278=	splice_region_variant&synonymous_variant				52	0.0
	MSH3(1.4%)	exon7,c.1148del,p.K383fs	0.014	0.015	1967|45	1311|29	0.01537	8714|136	5	79970914	79970915	CA	C	multiallelic,normal_artifact,panel_of_normals,slippage	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|none_provided|not_provided	44	0.0
	MSH3(1.2%)	exon7,c.1148dup,p.N385fs	0.012	0.022	1967|34	1311|37	0.01847	8714|164	5	79970914	79970915	CA	CAA	multiallelic,normal_artifact,panel_of_normals,slippage	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided	37	0.0
-	APC(54.2%)	exon13,c.1575C>A,p.C525*	0.542	0.001298	916|1074	1062|0	0.53986	3330|3907	5	112163652	112163652	C	A	PASS	APC	NM_000038.6	13	c.1575C>A	p.Cys525*	stop_gained				41	0.0
	RAD50(6.8%)	exon13,c.2165del,p.K722fs	0.068	0.05	5028|402	3863|243	0.04984	71429|3747	5	131931451	131931452	TA	T	multiallelic,normal_artifact,panel_of_normals,slippage	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome	44	0.0
	RAD50(1.4%)	exon13,c.2165dup,p.E723fs	0.014	0.015	5028|103	3863|99	0.03085	71429|2274	5	131931451	131931452	TA	TAA	multiallelic,normal_artifact,panel_of_normals,slippage	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided	41	0.0
	RAD50(5.3%)	exon23,c.3508G>A,p.D1170N	0.053	0.037	124|6	33|0	0.03681	157|6	5	131973805	131973805	G	A	PASS	RAD50	NM_005732.4	23	c.3508G>A	p.Asp1170Asn	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_benign(1),Uncertain_significance(1)	Hereditary_cancer-predisposing_syndrome	21	0.0
	FLT4(3.8%)	exon2,c.89del,p.P30fs	0.038	0.041	247|8	63|1	0.02375	370|9	5	180058747	180058748	CG	C	normal_artifact,panel_of_normals,weak_evidence	FLT4	NM_182925.5	2	c.89del	p.Pro30fs	frameshift_variant	Pathogenic		Congenital_heart_defects,_multiple_types,_7|not_provided	40	0.0
-	ARID1B(29.6%)	exon20,c.6776C>A,p.S2259*	0.296	0.007738	377|145	159|0	0.26643	614|223	6	157528682	157528682	C	A	PASS	ARID1B	NM_001374828.1	20	c.6776C>A	p.Ser2259*	stop_gained				43	0.0
	CARD11(40.6%)	exon21,c.2802G>A,p.S934=	0.406	0.071	27|19	13|0	0.46429	30|26	7	2954908	2954908	C	T	PASS	CARD11	NM_032415.7	21	c.2802G>A	p.Ser934=	synonymous_variant	Likely_benign		Immunodeficiency_11|B-cell_expansion_with_NFKB_and_T-cell_anergy|not_provided	30	0.0
	MAGI2(86.0%)	exon19,c.3357A>G,p.L1119=	0.86	0.161	5|31	5|0	0.82609	8|38	7	77756580	77756580	T	C	germline,panel_of_normals	MAGI2	NM_012301.4	19	c.3357A>G	p.Leu1119=	synonymous_variant	Benign		Nephrotic_syndrome_type_15|not_specified|not_provided	31	0.0
1	BRAF(0.1%)	exon15,c.1799T>A,p.V600E	0.0007359	0.0009403	3997|3	1418|0	0.00164	34125|56	7	140453136	140453137	A	T	clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1799T>A	p.Val600Glu	missense_variant	Pathogenic,_drug_response,_other		Cystic_epithelial_invagination_containing_papillae_lined_by_columnar_epithelium|Trametinib-Dabrafenib_Response|Vemurafenib-Cobimetinib_Response|Nephroblastoma|Cerebral_arteriovenous_malformation|Neoplasm|Melanoma|Papillary_thyroid_carcinoma|Multiple_myeloma|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Colonic_neoplasm|Neoplasm_of_ovary|Gastrointestinal_stromal_tumor|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Malignant_neoplastic_disease|Lung_carcinoma|Colorectal_cancer|Squamous_cell_carcinoma_of_the_head_and_neck|Cardio-facio-cutaneous_syndrome|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Germ_cell_tumor,_nonseminomatous|Astrocytoma,_low-grade,_somatic|not_provided	63	0.0
-	KMT2C(3.2%)	exon56,c.14344-2delinsTT	0.032	0.031	171|4	40|0	0.01515	260|4	7	151836878	151836878	T	AA	haplotype	KMT2C	NM_170606.3	55	c.14344-2delinsTT		splice_acceptor_variant&intron_variant				40	0.0
-	KMT2C(2.4%)	exon38,c.8390dup,p.E2798fs	0.024	0.032	3028|92	2689|108	0.04024	19104|801	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,panel_of_normals,slippage	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided	35	0.0
	ADGRA2(7.7%)	exon13,c.1914C>A,p.P638=	0.077	0.035	62|4	31|0	0.04878	78|4	8	37693152	37693152	C	A	orientation	ADGRA2	NM_032777.10	13	c.1914C>A	p.Pro638=	synonymous_variant				63	0.0
	PRKDC(13.3%)	exon5,c.496del,p.I166fs	0.133	0.044	112|15	28|0	0.08750	146|14	8	48866909	48866910	AT	A	panel_of_normals,slippage	PRKDC	NM_006904.7	5	c.496del	p.Ile166fs	frameshift_variant				44	0.0
	PTCH1(6.4%)	exon23,c.4265G>A,p.R1422K	0.064	0.038	59|4	26|0	0.04878	78|4	9	98209273	98209273	C	T	PASS	PTCH1	NM_000264.5	23	c.4265G>A	p.Arg1422Lys	missense_variant				32	0.0
	MUC6(2.1%)	exon31,c.4889_4890delinsAG,p.T1630K	0.021	0.019	411|6	64|0	0.04664	695|34	11	1017911	1017912	TG	CT	clustered_events,panel_of_normals	MUC6	NM_005961.3	31	c.4889_4890delinsAG	p.Thr1630Lys	missense_variant				53	0.0
	MUC6(2.4%)	exon31,c.4846G>A,p.V1616I	0.024	0.015	544|10	77|0	0.05508	875|51	11	1017955	1017955	C	T	clustered_events,panel_of_normals	MUC6	NM_005961.3	31	c.4846G>A	p.Val1616Ile	missense_variant				53	0.0
	MUC6(2.8%)	exon31,c.4837C>A,p.P1613T	0.028	0.02	323|8	49|0	0.03553	923|34	11	1017964	1017964	G	T	clustered_events,haplotype,panel_of_normals	MUC6	NM_005961.3	31	c.4837C>A	p.Pro1613Thr	missense_variant				37	0.0
	MUC6(3.8%)	exon31,c.4506A>G,p.I1502M	0.038	0.02	304|8	61|0	0.14032	484|79	11	1018295	1018295	T	C	clustered_events,panel_of_normals	MUC6	NM_005961.3	31	c.4506A>G	p.Ile1502Met	missense_variant				23	0.0
-	ATM(1.9%)	exon42,c.6100C>T,p.R2034*	0.019	0.008261	584|12	292|2	0.01229	1125|14	11	108186742	108186742	C	T	normal_artifact	ATM	NM_000051.4	42	c.6100C>T	p.Arg2034*	stop_gained	Pathogenic/Likely_pathogenic		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided	29	0.0
	CD3G(3.4%)	exon3,c.213del,p.K71fs	0.034	0.037	1394|68	564|27	0.03560	4307|159	11	118220582	118220583	TA	T	multiallelic,normal_artifact,panel_of_normals,slippage	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1),Uncertain_significance(1)	Immunodeficiency_17	45	0.0
	CD3G(1.5%)	exon3,c.213dup,p.W72fs	0.015	0.028	1394|26	564|15	0.03017	4307|134	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,panel_of_normals,slippage	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic		Immunodeficiency_17	40	0.0
	KMT2A(2.0%)	exon3,c.2318del,p.P773fs	0.02	0.008231	3460|101	1511|16	0.01108	16604|186	11	118344185	118344186	AC	A	normal_artifact,panel_of_normals	KMT2A	NM_001197104.2	3	c.2318del	p.Pro773fs	frameshift_variant	Pathogenic		Inborn_genetic_diseases	42	0.0
	KMT2A(1.5%)	exon35,c.11561C>T,p.A3854V	0.015	0.012	391|6	99|0	0.01258	628|8	11	118392050	118392050	C	T	PASS	KMT2A	NM_001197104.2	35	c.11561C>T	p.Ala3854Val	missense_variant				34	0.0
1	KRAS(0.1%)	exon4,c.436G>T,p.A146S	0.001271	0.001042	3566|3	2295|1	0.00135	34735|47	12	25378562	25378562	C	A	orientation,weak_evidence	KRAS	NM_033360.4	4	c.436G>T	p.Ala146Ser	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1),Uncertain_significance(1)	Rasopathy|not_provided	23	0.0
1	KRAS(0.1%)	exon4,c.436G>A,p.A146T	0.001169	0.000596	3566|3	2295|0	0.00118	34735|41	12	25378562	25378562	C	T	orientation,weak_evidence	KRAS	NM_033360.4	4	c.436G>A	p.Ala146Thr	missense_variant	Uncertain_significance		OCULOECTODERMAL_SYNDROME,_SOMATIC|Neoplasm_of_the_large_intestine|not_provided	37	0.0
1	KRAS(0.2%)	exon2,c.38G>T,p.G13V	0.001578	0.0004149	3518|6	3162|0	0.00111	28826|32	12	25398281	25398282	C	A	clustered_events,weak_evidence	KRAS	NM_033360.4	2	c.38G>T	p.Gly13Val	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine|not_provided	30	0.0
	FAM186A(15.5%)	exon4,c.4831_4835delinsGGA,p.Q1611fs	0.155	0.111	54|8	8|0	0.05556	136|8	12	50745780	50745784	CCCTG	TCC	clustered_events,haplotype,panel_of_normals	FAM186A	NM_001145475.3	4	c.4831_4835delinsGGA	p.Gln1611fs	frameshift_variant&missense_variant				2	0.0
	FRS2(0.9%)	exon10,c.488C>T,p.P163L	0.00931	0.00423	899|8	316|0	0.00490	1624|8	12	69965973	69965973	C	T	PASS	FRS2	NM_001278351.2	10	c.488C>T	p.Pro163Leu	missense_variant				48	0.0
	NCOR2(8.6%)	exon38,c.5488+1G>T	0.086	0.083	45|4	15|0	0.07018	53|4	12	124824839	124824839	C	A	PASS	NCOR2	NM_006312.6	38	c.5488+1G>T		splice_donor_variant&intron_variant				48	0.0
-	BRCA2(2.4%)	exon10,c.1813del,p.I605fs	0.024	0.019	2622|73	832|19	0.02299	9817|231	13	32907420	32907421	GA	G	normal_artifact,panel_of_normals,slippage	BRCA2	NM_000059.4	10	c.1813del	p.Ile605fs	frameshift_variant	Pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Fanconi_anemia,_complementation_group_D1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|not_provided	34	0.0
-	BRCA2(1.0%)	exon11,c.5073del,p.K1691fs	0.009533	0.017	2372|30	652|10	0.01111	7656|86	13	32913558	32913559	CA	C	normal_artifact,weak_evidence	BRCA2	NM_000059.4	11	c.5073del	p.Lys1691fs	frameshift_variant	Pathogenic		Breast-ovarian_cancer,_familial_2|not_provided	42	0.0
-	BRCA2(0.7%)	exon11,c.5351del,p.N1784fs	0.00718	0.007419	2346|29	760|9	0.00658	7845|52	13	32913836	32913837	CA	C	normal_artifact,panel_of_normals,weak_evidence	BRCA2	NM_000059.4	11	c.5351del	p.Asn1784fs	frameshift_variant	Pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|not_provided	40	0.0
-	BRCA2(1.0%)	exon23,c.9097del,p.T3033fs	0.01	0.006897	2037|20	844|5	0.00934	7740|73	13	32954022	32954023	CA	C	multiallelic,normal_artifact,panel_of_normals,slippage	BRCA2	NM_000059.4	23	c.9097del	p.Thr3033fs	frameshift_variant	Pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided	20	0.0
-	BRCA2(2.8%)	exon23,c.9097dup,p.T3033fs	0.028	0.02	2037|55	844|15	0.02445	7740|194	13	32954022	32954023	CA	CAA	multiallelic,normal_artifact,panel_of_normals,slippage	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Breast_carcinoma|Neoplasm_of_ovary|Hereditary_breast_and_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial_1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided	40	0.0
	SMAD3(7.2%)	exon5,c.626C>T,p.P209L	0.072	0.1	58|4	13|0	0.05405	70|4	15	67462910	67462910	C	T	orientation	SMAD3	NM_005902.4	5	c.626C>T	p.Pro209Leu	missense_variant	Uncertain_significance		Familial_thoracic_aortic_aneurysm_and_aortic_dissection	44	0.0
	SMAD3(47.4%)	exon8,c.1125C>A,p.S375R	0.474	0.071	11|10	13|0	0.45833	13|11	15	67479818	67479818	C	A	PASS	SMAD3	NM_005902.4	8	c.1125C>A	p.Ser375Arg	missense_variant				24	0.0
	BLM(3.3%)	exon7,c.1544del,p.N515fs	0.033	0.024	4143|177	5073|148	0.02176	70389|1566	15	91304138	91304139	GA	G	multiallelic,normal_artifact,panel_of_normals,slippage	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome	39	0.0
	BLM(1.0%)	exon7,c.1544dup,p.N515fs	0.009727	0.021	4143|58	5073|143	0.02562	70389|1851	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,panel_of_normals,slippage	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome	39	0.0
	CHD2(3.0%)	exon29,c.3734del,p.K1245fs	0.03	0.017	479|17	241|9	0.02421	1048|26	15	93540315	93540316	GA	G	multiallelic,normal_artifact,panel_of_normals,slippage	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Pathogenic/Likely_pathogenic		Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_provided	34	0.0
	CHD2(6.6%)	exon33,c.4173dup,p.Q1392fs	0.066	0.033	166|11	105|3	0.06944	335|25	15	93545433	93545433	G	GA	normal_artifact,panel_of_normals,slippage	CHD2	NM_001271.4	33	c.4173dup	p.Gln1392fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(3),Uncertain_significance(1)	CHD2-Related_Disorder|Autistic_behavior|Seizures|Developmental_and_epileptic_encephalopathy_94|Complex_neurodevelopmental_disorder|not_provided	35	0.0
	PALB2(0.8%)	exon4,c.886del,p.M296*	0.008481	0.008849	2204|20	1619|20	0.00618	16092|100	16	23646980	23646981	AT	A	normal_artifact,panel_of_normals,weak_evidence	PALB2	NM_024675.4	4	c.886del	p.Met296*	frameshift_variant&stop_gained	Pathogenic		Familial_cancer_of_breast|not_provided	36	0.0
	TP53(40.1%)	exon5,c.524G>A,p.R175H	0.401	0.004442	711|455	1201|4	0.39784	2841|1877	17	7578406	7578406	C	T	PASS	TP53	NM_000546.6	5	c.524G>A	p.Arg175His	missense_variant	Pathogenic		Li-Fraumeni_syndrome_1|Hepatocellular_carcinoma|Neoplasm|Breast_neoplasm|Neoplasm_of_ovary|Choroid_plexus_papilloma|Carcinoma_of_colon|Bone_osteosarcoma|Carcinoma_of_pancreas|Colorectal_cancer|Malignant_tumor_of_esophagus|Adrenocortical_carcinoma,_hereditary|Squamous_cell_carcinoma_of_the_head_and_neck|Basal_cell_carcinoma,_susceptibility_to,_7|Hereditary_cancer-predisposing_syndrome|Nasopharyngeal_carcinoma|Familial_cancer_of_breast|Li-Fraumeni_syndrome|Lip_and_oral_cavity_carcinoma|Glioma_susceptibility_1|not_provided	36	0.0
	AURKB(11.5%)	exon7,c.597A>T,p.R199S	0.115	0.143	29|4	5|0	0.09756	37|4	17	8109898	8109898	T	A	PASS	AURKB	NM_004217.4	7	c.597A>T	p.Arg199Ser	missense_variant				34	0.0
	KRT15(1.7%)	exon3,c.604C>T,p.R202C	0.017	0.012	404|8	109|0	0.01229	643|8	17	39673194	39673194	G	A	PASS	KRT15	NM_002275.4	3	c.604C>T	p.Arg202Cys	missense_variant				37	0.0
	XYLT2(1.4%)	exon8,c.1584del,p.G529fs	0.014	0.011	955|19	401|7	0.01045	2273|24	17	48433966	48433967	AC	A	normal_artifact,panel_of_normals,weak_evidence	XYLT2	NM_022167.4	8	c.1584del	p.Gly529fs	frameshift_variant	Likely_pathogenic		Spondyloocular_syndrome	48	0.0
	GNA13(2.4%)	exon2,c.295C>T,p.L99=	0.024	0.018	293|5	67|0	0.01142	433|5	17	63049835	63049835	G	A	PASS	GNA13	NM_006572.6	2	c.295C>T	p.Leu99=	synonymous_variant				43	0.0
-	SOX9(50.0%)	exon3,c.770_771dup,p.P258fs	0.5	0.143	6|6	5|0	0.47059	9|8	17	70119765	70119765	G	GGC	PASS	SOX9	NM_000346.4	3	c.770_771dup	p.Pro258fs	frameshift_variant				49	0.0
	SMAD2(1.7%)	exon10,c.1211C>T,p.A404V	0.017	0.009647	474|8	122|0	0.01099	900|10	18	45371780	45371780	G	A	PASS	SMAD2	NM_005901.6	10	c.1211C>T	p.Ala404Val	missense_variant				44	0.0
	DOT1L(18.9%)	exon19,c.1813G>A,p.E605K	0.189	0.019	168|35	70|0	0.20923	257|68	19	2214485	2214485	G	A	PASS	DOT1L	NM_032482.3	19	c.1813G>A	p.Glu605Lys	missense_variant				36	0.0
	ZNF429(2.9%)	exon4,c.1110_1277del,p.K370_Y425del	0.029	0.005158	1262|70	302|10	*	0|0	19	21719956	21720124	GCCCTACAAATGTGAAGAATGTGGCAAAGCTTTTAACCAGTCTTCAAGACTTACTCGACATAAAAAAATTCATACTGGAGAGGAACCCTACAAATTTGAAAAATGTGGCAGAGTTTTTACCTGTTCCTCAACACTTACTCAAGACAAGAAAATTCATACTGGAGAGAAA	G	clustered_events,panel_of_normals	ZNF429	NM_001001415.4	4	c.1110_1277del	p.Lys370_Tyr425del	disruptive_inframe_deletion				28	0.0
	ZNF429(2.8%)	exon4,c.1467_1634del,p.F490_A545del	0.028	0.032	1075|37	235|6	*	0|0	19	21720295	21720463	CTACAAATGTGAAGAATGTGGCAAAGCCTTTAAGCAGTCCTCAAACCTTAACAGTCATAAAAAAATTCATAGTGGAGAGAAACCCTACAAATGTGAAGAATGTGGCAAAGCTTTTATCCTGTCCTCAAGACTTACTCAACATAAGAAAATTCATACTGGAGAGAAACCT	C	clustered_events,panel_of_normals	ZNF429	NM_001001415.4	4	c.1467_1634del	p.Phe490_Ala545del	disruptive_inframe_deletion				26	0.0
	ZNF429(2.1%)	exon4,c.1893C>T,p.T631=	0.021	0.018	1256|26	292|4	0.03744	2931|114	19	21720748	21720748	C	T	clustered_events,panel_of_normals	ZNF429	NM_001001415.4	4	c.1893C>T	p.Thr631=	synonymous_variant				32	0.0
	BAX(1.6%)	exon3,c.121del,p.E41fs	0.016	0.021	1166|24	358|8	0.01484	2788|42	19	49458970	49458971	TG	T	multiallelic,normal_artifact,panel_of_normals,slippage,weak_evidence	BAX	NM_138761.4	3	c.121del	p.Glu41fs	frameshift_variant	Pathogenic		Carcinoma_of_colon	46	0.0
	C21orf58(14.4%)	exon8,c.906G>A,p.W302*	0.144	0.137	23|4	7|0	0.11765	30|4	21	47721976	47721976	C	T	clustered_events	C21orf58	NM_058180.5	8	c.906G>A	p.Trp302*	stop_gained				61	0.0
	MED12(3.4%)	exon13,c.1964_1966del,p.S655del	0.034	0.019	151|5	44|0	0.02216	353|8	X	70344215	70344218	GGCA	G	panel_of_normals,slippage	MED12	NM_005120.3	13	c.1964_1966del	p.Ser655del	disruptive_inframe_deletion				22	0.0
